69 Biotech Startups in Switzerland to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Advanced allosteric modulator therapeutics developer for neurological disorders. |
$63M · Series A | Xontogeny, Perceptive Advisors, Acorn Bioventures | 1 to 10 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@neurosterix.com | ||
Gene therapy platform. |
$6M · Seed | Life Extension Ventures, Zühlke Group, Oxford Seed Fund | 1 to 10 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@limula.ch | ||
Viral vector-based cancer vaccines developer. |
$82M · Series C | Bpifrance, 5AM Ventures, Abingworth | 1 to 10 | Health Tech, Biotech | B2C | Basel, Switzerland | •••••••••••@nouscom.com | |
Novel antiobiotic researcher to fight antimicrobial resistance. |
$13M · Series C | AMR Action Fund, GSK | 1 to 10 | Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@bioversys.com | |
Developer of small molecules to treat novel drug resistance pathways in cancer therapy. |
$20M · Series A | Altos Ventures, BioMedPartners, Redalpine | 1 to 10 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@tolremo.com | ||
Precision medicine developer for neuropsychiatric and neurological disorders. |
$13M · Series B | SPRIM Global Investments | 11 to 50 | Biotech | Geneva, Switzerland | •••••••••••@stalicla.com | ||
Antibody discovery and human immune repertoire analysis platform. |
$27M · Series C | Vesalius Biocapital Partners, Swisscanto Private Equity, Pureos Bioventures | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@memo-therapeutics.com | |
Generative AI platform for protein design and engineering. |
$24M · Series A | Index Ventures, Kindred Capital | 11 to 50 | AI, Biotech | B2B | Zürich, Switzerland | •••••••••••@cradle.bio | |
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
Small molecule mitophagy inducers developer. |
$20M · Series A | ND Capital | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@vandria.com | ||
Therapeutics developer for mast cell-mediated diseases. |
$3M · Seed | Forty51 Ventures | 1 to 10 | Health Tech, Biotech | Basel, Switzerland | •••••••••••@allegriatx.com | ||
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
Self-adjuvanting and multi-antigen vaccine technology platform. |
$3M · Series A | AXA Investment Managers, Novo A/S, Adjuvant Capital | 11 to 50 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@lmtbio.com | ||
Non-invasive treatment for heart arrhythmias. |
$15M · Series A | EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Biotech | B2B | Geneva, Switzerland | •••••••••••@eba-med.com | |
Clinical-stage central nervous system (CNS) technology. |
$110M · Series B | Sofinnova Partners, Forbion Capital Partners, BioMedPartners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@noemapharma.com | |
Platform providing digital assessments and therapies for patient treatment and rehabilitation. |
$125M | Hambro Perks Ltd. | 101 to 250 | Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence | B2B | Lausanne, Switzerland | •••••••••••@mindmaze.com | |
RNA sequencing and transcriptomics analysis platform. |
$3M · Seed | Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) | 1 to 10 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@alitheagenomics.com | |
Producer of ethanol-free perfume pearls. |
$10M · Series A | Helvetica Capital, Zürcher Kantonal Bank, ETH Zurich Foundation | 11 to 50 | Biotech, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@microcaps.ch | |
Biotech company creating meat and dairy alternatives using biomass and precision fermentation techniques. |
$8M · Seed | XAnge, Astanor Ventures, Nucleus Capital | 11 to 50 | Foodtech, Biotech, Manufacturing | B2B | Geneva, Switzerland | •••••••••••@planetarygroup.ch | |
Clinical-stage biotechnology developing treatments for cancer. |
$85M · Series B | EIC Accelerator, Syncona Partners LLP, M Ventures | 11 to 50 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@ionctura.com | ||
Molecular analysis technology developer. |
$1M · Pre Seed | Tiny VC, another.vc, Founderful | 1 to 10 | Biotech | B2B | Lausanne, Switzerland | •••••••••••@isospecanalytics.com | |
Accurate monitoring and treatment platform for sleep bruxism and sleep apnea. |
$3M · Seed | Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@aesyra.com | ||
Manufacturer of drugs to combat the effects of ageing. |
$10M · Series A | Prima Materia | 11 to 50 | Health Tech, Biotech | B2C | Lausanne, Switzerland | •••••••••••@epiterna.com | |
Clinical biotech firm focused on revolutionizing cell invasion research. |
$4M · Seed | High-Tech Gründerfonds, Verve Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Zürich, Switzerland | •••••••••••@invasight.com | |
Platform engineering next-generation T cell receptor therapies. |
$15M · Seed | Novo A/S, Pureos Bioventures | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Basel, Switzerland | •••••••••••@engimmune.com | |
Program to increase human lifespan. |
$5M · Seed | Maximon | 11 to 50 | Health Tech, Biotech | B2C | Zug, Switzerland | •••••••••••@biolytica.com | |
Platform for observing live cells in 3D without damaging them. |
$20M | Swisscom Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Lausanne, Switzerland | •••••••••••@nanolive.ch | |
Biotechnology platform developing therapies by investing in people and ideas. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, Gimv, BioMedPartners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
Compounds for immunotherapy and metabolic diseases. |
$1M · Seed | Plutus Investment Group | 1 to 10 | Biotech | Geneva, Switzerland | •••••••••••@mpc-therapeutics.com | ||
Platform creating soft implantable electrodes for nervous system interfaces. |
$169k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing | B2B | Geneva, Switzerland | •••••••••••@neurosoft-bio.com | |
Platform offering tools to enhance the development of personalized and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Developer of an antibody-drug conjugates (ADCs). |
$110k · Pre Seed | btov Partners, Pureos Bioventures, Redalpine | 1 to 10 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@ararisbiotech.com | |
Bio-based and biodegradable foam solutions for fast disposables. |
$161k · Pre Seed | Venture Kick | Agritech, Biotech, Energy & Nuclear, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@groamtech.com | ||
Gene and cell therapy manufacturing. |
$50M · Series A | 101 to 250 | Biotech | Lausanne, Switzerland | •••••••••••@newbiologix.com | |||
Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist. |
$80M · Series C | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Zug, Switzerland | •••••••••••@pharvaris.com | ||
Pathogen detection technology that provides accurate results in under 2 hours. |
$6M · Series B | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B | Zürich, Switzerland | •••••••••••@rqmicro.com | ||
Biotechnology company creating vaccines and immunotherapies. |
$8M · Series B | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@virometix.com | ||
Medical robotics company. |
$12M · Series A | 11 to 50 | Biotech | Zürich, Switzerland | •••••••••••@nanoflexrobotics.com | |||
Clinical-stage biopharmaceutical company developing drugs for rare diseases. |
$16M · Series A | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Geneva, Switzerland | •••••••••••@chordtherapeutics.com | ||
Quantum sensing technology for nanoscale imaging. |
$2M · Seed | Quantonation, High-Tech Gründerfonds, Verve Ventures | 11 to 50 | Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing | B2B | Basel, Switzerland | •••••••••••@qnami.ch | |
True precision medicine through single-cell science |
$1M · Series A | Verve Ventures, Swisscom Ventures | 11 to 50 | Health Tech, AI, Biotech | B2B | Basel, Switzerland | •••••••••••@scailyte.com | |
Platform that identifies the ideal treatment for each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies. |
$30M · Series A | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Basel, Switzerland | •••••••••••@vectorbiopharma.com | ||
Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders. |
$50M · Series A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cimeio.com | ||
Treatments that improve the lives of cancer patients with innovative approaches. |
$26M · Series C | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Basel, Switzerland | •••••••••••@t3pharma.com | ||
Guided medical devices cardiovascular procedures. |
$4M · Series B | 1 to 10 | Biotech | Zürich, Switzerland | •••••••••••@medyria.com | |||
Rheon focuses on the development of first-in-class glaucoma drainage devices. |
$6M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@rheonmedical.com | ||
Self-testing kit provider for quick, at-home medical results. |
$1M · Seed | Next Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B, B2C | Lausanne, Switzerland | •••••••••••@testmatehealth.com | |
Platform focusing on the discovery and development of next-generation RNA-based drugs. |
$6M · Seed | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@versameb.com | ||
Biotechnology company developing treatments to enhance immune system responses. |
$154k · Pre Seed | Venture Kick | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@nextimmune.com | ||
Antibiotic resistance test. |
$9M · Series B | 1 to 10 | Biotech, Deep Tech | Basel, Switzerland | •••••••••••@resistell.com | |||
Next-gen IgV therapeutics developer. |
$656k · Pre Seed | High-Tech Gründerfonds | 1 to 10 | Biotech | Basel, Switzerland | •••••••••••@phialogics.com | ||
We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech | B2B | Lausanne, Switzerland | •••••••••••@flowbone.com | |
Device that automatically inspects and sorts miniature biological entities. |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Biotech, Machine Learning, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@bionomous.ch | |
Protein engineering platform using cell-free synthetic biology and nanofluidics. |
$125k · Pre Seed | Y Combinator, Wingman Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@adaptyvbio.com | |
Platform for sharing and interacting with video games using emotions. |
$1M | 1 to 10 | Gaming, Biotech, Data and Analytics, Business Intelligence | B2B, SaaS | Geneva, Switzerland | •••••••••••@ovomind.com | ||
AI-powered biotech research platform. |
$110k · Pre Seed | 1 to 10 | Biotech, Data and Analytics | B2B, SaaS | Geneva, Switzerland | •••••••••••@aequicens.com | ||
Chemicals company producing sustainable chemicals. |
$308k · Pre Seed | 1 to 10 | Biotech, Deep Tech, Proptech & Real Estate, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@biosimo-chemicals.com | ||
System improving honey bee health by using heat to combat the varroa mite. |
$1M | 1 to 10 | Climate Tech & Green Tech, Agritech, Hardware, Biotech | B2B | Zürich, Switzerland | •••••••••••@vatorex.ch | ||
Device improving comfort during gynecological procedures. |
$5M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@aspivix.com | ||
Preventive health technology. |
$4M · Pre Seed | 11 to 50 | Health Tech, Biotech | Basel, Switzerland | •••••••••••@aera.health | |||
Clinical stage artificial heart valve. |
$2M · Series A | 1 to 10 | Biotech | B2C | Bern, Switzerland | •••••••••••@novostia.com | ||
Preclinical-stage oncology platform. |
$1M · Seed | 1 to 10 | Health Tech, Biotech | Basel, Switzerland | •••••••••••@ymmunobio.com | |||
Bloom Biorenewables is making biomass a true alternative to petroleum. |
$3M | 1 to 10 | Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing | B2B | Fribourg, Switzerland | •••••••••••@bloombiorenewables.com | ||
Solutions that advance neuroscience research and speed up preclinical drug discovery. |
$4M · Series A | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Basel, Switzerland | •••••••••••@mxwbio.com | ||
Software platform that accelerates innovation in the pharmaceutical industry. |
N/A | BACKED VC, Speedinvest, BoxGroup | 11 to 50 | Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma | B2B, Marketplace | Schaffhausen, Switzerland | •••••••••••@molecule.to | |
The Tokenised Cloud - Sustainable, Decentralised |
$2M · Pre Seed | 11 to 50 | Climate Tech & Green Tech, Health Tech, Crypto & web3, Biotech, Deep Tech, Manufacturing | B2B, SaaS | Zug, Switzerland | •••••••••••@deepsquare.io | ||
Biotech firm focused on creating personalized molecular therapies for cancer patients. |
$1M · Seed | 11 to 50 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@ac-bioscience.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.